Advertisement
Advertisement
RAPP
Rapport Therapeutics, Inc. Common Stock
40.45
USDSponsored
-1.50
-3.58%
Sep 18, 15:59 UTC -4
Closed
After-Market
40.48
+0.03
+0.07%
Rapport Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 1.94B |
| Beta | 1.02 |
| Earnings Per Share (EPS) | -3.04 |
| Price-to-Book (P/B) Ratio | 4.57 |
| Operating Margin | -- |
| Total Debt/Equity (D/E) | 0.00% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -29.02% |
| Current Ratio | 15.72% |
| Free Cash Flow | -54.49M |
